The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: focus on fixed-dose combination antihypertensive therapy

Renal Failure
M Epstein

Abstract

During the past two decades, major investigative interest has been focused on the determinants of chronic renal disease and interventions to retard the inexorable progression to end-stage renal disease. Recent studies have provided a theoretic framework for anticipating that angiotensin-converting enzyme (ACE) inhibitors, and possibly calcium antagonists, may preferentially retard the progression of renal disease. Whereas the majority of available clinical trials have assessed the effects of ACE inhibitors in patients with insulin-dependent diabetes mellitus (IDDM), there are relatively few long-term studies that have evaluated the renal protective effects of ACE inhibitors and calcium antagonists in patients with nondiabetic renal disease. Although clinical trials have been initiated using both of these drug classes as monotherapy, theoretical considerations suggest that fixed-dose combinations of an ACE inhibitor and a calcium antagonist might be appealing as renal protective agents. Several lines of evidence suggest that the renal microcirculatory effects of coadministration of both agents should be complementary. Similarly, recent observations suggest that the two classes may act in a complementary manner to countervail pat...Continue Reading

References

Dec 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R W Schrier, S Savage
Sep 1, 1992·The Journal of Clinical Investigation·R A LafayetteT W Meyer
Jan 1, 1992·Annual Review of Medicine·J R Diamond, M J Karnovsky
Apr 1, 1992·Journal of the American Society of Nephrology : JASN·L G Fine, J T Norman
Jul 1, 1992·American Journal of Hypertension·A L KamperP P Leyssac
Oct 1, 1991·Kidney International·I Ichikawi, R C Harris
Jul 1, 1990·Journal of the American Society of Nephrology : JASN·W G Couser
Oct 1, 1990·Cardiovascular Drugs and Therapy·L D Dworkin
Dec 28, 1989·The New England Journal of Medicine·B U IhleP S Kincaid-Smith
Mar 1, 1989·Kidney International·L D DworkinM Parker
Dec 1, 1989·Kidney International·F P BrunnerM J Mihatsch
Feb 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L M RuilopeL Raij
Mar 1, 1987·Kidney International·T W MeyerB M Brenner
Sep 1, 1988·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R W SchrierC Caramelo
Feb 1, 1988·The American Journal of Physiology·R C Stanton, J L Seifter
Jun 23, 1988·The New England Journal of Medicine·S KlahrI Ichikawa
Jan 1, 1987·Kidney International·D C HarrisR W Schrier
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M L PurkersonS Klahr
May 1, 1985·Kidney International·M S GoligorskyR Kol
Sep 27, 1985·The American Journal of Medicine·L Raij, W F Keane
Sep 1, 1983·Hypertension·M StornelloA Salvetti
May 1, 1984·The Journal of Clinical Investigation·L D DworkinB M Brenner
Jan 4, 1996·The New England Journal of Medicine·M J KlagJ Stamler
Jan 1, 1993·Drugs·S OrthE Ritz
Jun 1, 1995·Clinical Cardiology·M Epstein
Jan 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H R Jacobson, G E Striker

❮ Previous
Next ❯

Citations

Apr 8, 1998·Current Opinion in Nephrology and Hypertension·M Epstein
Jun 3, 1998·Intensive Care Medicine·R B Rao, L R Goldfrank
Sep 12, 2000·Current Hypertension Reports·A A Taylor, S Sunthornyothin
Jun 21, 2002·American Journal of Hypertension·Franz H MesserliJoel M Neutel
Dec 9, 1998·Kidney International·M Epstein
Aug 26, 1998·The Medical Clinics of North America·J B Marks, P Raskin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
M Epstein
Journal of Cardiovascular Pharmacology
K Makrilakis, G L Bakris
© 2021 Meta ULC. All rights reserved